Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz hp ## Overview Sompraz hp is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. ## Primary Indications Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease. ## Adult Dosing **Sompraz hp:** One dual-chamber pack taken twice daily for 7 to 14 days. Each dual-chamber pack contains: * Pantoprazole 40 mg * Amoxicillin 500 mg * Clarithromycin 500 mg ## Pediatric Dosing Pediatric dosing is not established for Sompraz hp. Dosing of individual components will vary based on age and weight. ## Dose Adjustments No dose adjustments are typically required for renal or hepatic impairment for this specific combination product. However, individual component guidelines may suggest adjustments. ## Contraindications * Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or other macrolides. * History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use. * Severe renal impairment (for amoxicillin). * Concomitant use with ergotamine derivatives (for clarithromycin). ## Adverse Effects Common adverse effects include diarrhea, nausea, abdominal pain, headache, rash, and dysgeusia. Clarithromycin can also cause QT prolongation. ## Key Drug Interactions * **Pantoprazole:** May affect absorption of drugs requiring acidic environments (e.g., ketoconazole, iron salts). * **Amoxicillin:** May decrease the efficacy of oral contraceptives. * **Clarithromycin:** Significant interactions with CYP3A4 substrates (e.g., statins, warfarin, certain anticonvulsants, colchicine), potentially increasing their levels and toxicity. Avoid use with colchicine and specific statins. ## Monitoring * Monitor for signs and symptoms of gastrointestinal upset, allergic reactions, and *Clostridioides difficile*-associated diarrhea. * Consider monitoring for QT prolongation in patients with risk factors. * Assess for *H. pylori* eradication (e.g., urea breath test, stool antigen test) after treatment completion, as per local guidelines. ## Clinical Pearls * Administer the entire contents of one dual-chamber pack twice daily for the prescribed duration. * Pantoprazole should be taken 30 minutes before a meal. * Ensure patient compliance to maximize eradication rates. * Consider local resistance patterns for *H. pylori* when selecting empiric therapy. *** *This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines before making clinical decisions.*